<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8">
  <meta http-equiv="X-UA-Compatible" content="IE=edge">
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <link rel="shortcut icon" href="../images/favicon.png" type="image/x-icon">
  <title>Drug Treatment: Antipsychotics, Antidepressants, Lithium And Other Mood Stabilizers</title>
  <link href="https://cdn.jsdelivr.net/npm/remixicon@2.5.0/fonts/remixicon.css" rel="stylesheet">
  <link rel="stylesheet" href="../style.css">
  <link rel="stylesheet" href="../notes.css">

</head>
<body>
  <input type="checkbox" id="main-navigation-toggle" class="btn btn--close" title="Toggle main navigation" />
  <label for="main-navigation-toggle">
    <span></span>
  </label>
  
  <a href="../index.html">
   <div class="home-navigation">
      mtr<span class="logo-dot">.</span>
    </div>
  </a>


    <nav id="main-navigation" class="nav-main">
    <ul class="menu">
      <li class="menu__item">
        <a class="menu__link" href="../index.html">Home</a>
      </li>

      <li class="menu__item">
        <a class="menu__link" href="../about-temp2.html">About</a>
      </li>
    </ul>
  </nav>
  
      <!-- Toggle switch for dark mode -->
      <div class="dark-mode-toggle">
        <label class="switch-toggle">
            <input type="checkbox" id="dark-mode-toggle-checkbox">
            <span class="toggle-slider"></span>
        </label>
      </div>

      <!-- Progress Bar  -->
      <div id="progress-container">
        <div id="progress-bar"></div>
    </div>
      
<!-- SIDEBAR -->
<div id="sidebar" class="sidebar">
  <button id="closeSidebarBtn" class="btn toggle-btn close-btn">Close</button>
  <ul class="sidebar-menu toggle-menu">
    <!-- Add the list of topics dynamically using JavaScript -->
  </ul>
</div>

<!-- Toggle button to open the sidebar -->
<button id="toggleSidebarBtn" class="btn toggle-btn">&#9776;</button>

<!-- END OF SIDEBAR -->

  <main class="page-container">
    <div class="contribute-cta">
      <p>Help make this betterüíú</p>
      <span><a href="../contribute.html">Contribute here</a> </span>
    </div>


  <!-- TOPIC AND IMAGE CONTAINER  -->


      <h1>Drug Treatment: Antipsychotics, Antidepressants, Lithium And Other Mood Stabilizers</h1>


  <!-- END OF TOPIC AND IMAGE CONTAINER  -->
  


    <article class="notes">
        <a id='top'></a>
    <article>

          <!-- LEARNING OBJECTIVES CONTAINER  -->
              <div class="custom-card" id="custom-card-1">
                <div class="icon"><img src="../images/icons/light-bulb.png" alt="Icon" class="icon"></div>
                <div class="title"> 
                  <h2>What You Will Learn</h2>
                </div>
                <div class="line">
                  <p>After reading this note, you should be able to...</p>
                </div>
                <div class="content">
                  <ul>
                    <li><i>This content is not available yet.</i></li>
                </ul>
                </div>
                <div class="read-more" onclick="toggleContent('custom-card-1')">Read More üç™</div>
              </div>
            
          <!-- END OF LEARNING OBJECTIVES CONTAINER  -->
        
        
          <!-- SHOW AND HIDE OUTLINE CONTAINER  -->
            <div class="outline2">
        
              <input type="radio" name="control-2" id="show-2">
              <label for="show-2">üêµ&nbsp; &nbsp;Show Outline</label>
              <input type="radio" name="control-2" id="hide-2">
              <label for="hide-2">üôà&nbsp; &nbsp; Hide Outline</label>
              <div class="contents">
                <div class="icon-box">
                  <!-- Replace 'path/to/your/icon.png' with the actual path to your PNG icon -->
                  <img src="../images/icons/book.png" alt="Icon" class="icon">
                </div>
                <div id="tableOfContents">
                    <ol id="tocList"></ol>
                </div>
              </div>
             <div>
        
        <!-- END OF SHOW AND HIDE OUTLINE CONTAINER  -->
        
        
        <!-- READ SUMMARY CONTAINER -->
        
              <!-- Summary Overlay -->
              <div class="summary-overlay" id="summaryOverlay"></div>
        
        
              <div class="summary-card" id="summaryCard">
                
                <div class="summary-header">
                  <h3>Note Summary</h3>
                  <div class="icon-box">
                    <!-- Replace 'path/to/your/icon.png' with the actual path to your PNG icon -->
                    <img src="../images/icons/summary.png" alt="Icon" class="icon">
                  </div>
                </div>
                <div class="summary-content">
                  <!-- Summary content goes here -->
                  <p><i>This content is not available yet.</i></p>
        
                  <span class="close-btn" id="closeBtn">close</span>
                </div>
              </div>
        
              <div class="summary-trigger" id="summaryTrigger">
                <p>Click here to read a summary</p>
            </div>
        <!-- END OF READ SUMMARY CONTAINER -->
        
            <!-- BEGINNING OF NOTE -->
        
      <section id='header-1'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-1'>Introduction</a>
          </h2>
        </header>
        <div class='body'>

          <p>Antipsychotics are drugs that act on the brain to reduce psychomotor excitement and control symptoms of psychosis. They work to diminish hallucinations, delusions, agitation, and psychomotor excitement observed in schizophrenia, mania, or psychosis associated with a general medical condition.</p>
          
          <p>Generally, antipsychotics function by blocking dopamine receptors, primarily the D2 receptors, while also affecting alpha adrenergic, histaminergic, and muscarinic receptors.</p>
          
          <p>The side effects are linked to their antidopaminergic, antiadrenergic, anti-histaminergic, and anti-muscarinic activity.</p>
          
          <h4>Dopamine Theory</h4>
          
          <p>The dopamine hypothesis of psychosis suggests that overactivity of dopamine neurons in the mesolimbic pathway of the brain may mediate the positive symptoms of psychosis.</p>
          
          <p>The mesolimbic pathway is responsible for pleasure, the effects of drugs and alcohol, as well as hallucinations and delusions.</p>
          
          
        </div>
      </section>

      <section id='header-2'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-2'>Classification of Antipsychotics</a>
          </h2>
        </header>
        <div class='body'>
          <p>Antipsychotics are broadly categorized into typical and atypical antipsychotics. Additionally, they can be grouped based on their chemical composition:</p>
          
          <ul>
            <li><strong>Phenothiazines:</strong> Further grouped into</li>
            <ul>
              <li>A: Aliphatic side chain, e.g., chlorpromazine</li>
              <li>B: Piperazine side chain, e.g., trifluoperazine, fluphenazine</li>
              <li>C: Piperidine side chain, e.g., thioridazine, pipothiazine</li>
            </ul>
            <li><strong>Thioxanthines:</strong> e.g., flupenthixol, clopenthixol, zuclopenthixol</li>
            <li><strong>Butyrophenones:</strong> e.g., haloperidol, droperidol</li>
            <li><strong>Diabenzodiazepines:</strong> e.g., clozapine and olanzapine</li>
            <li><strong>Diabenzothiazepines:</strong> e.g., quetiapine</li>
            <li><strong>Substituted Benzamides:</strong> e.g., sulpiride and amisulpiride</li>
            <li><strong>Benzisoxazole:</strong> e.g., risperidone</li>
          </ul>
          

          <table class="note-table">
            <tr>
              <th colspan="2" >CLASSIFICATION OF ANTIPSYCHOTIC DRUGS</th>
            </tr>
            <tr>
              <td>Typical Antipsychotics</td>
              <td>Atypical Antipsychotics</td>
            </tr>
            <tr>
              <td>
                <ul>
                  <li>Phenothiazines</li>
                  <ul>
                    <li>e.g., chlorpromazine, thioridazine</li>
                  </ul>
                  <li>Butyrophenones</li>
                  <ul>
                    <li>e.g., haloperidol, droperidol</li>
                  </ul>
                  <li>Thioxanthenes</li>
                  <ul>
                    <li>e.g., chlorprothixen, thiothixene</li>
                  </ul>
                </ul>
              </td>
              <td>
                <ul>
                  <li>Clozapine</li>
                  <li>Risperidone</li>
                  <li>Sertindole</li>
                  <li>Olanzapine</li>
                  <li>Quetiapine</li>
                </ul>
              </td>
            </tr>
          </table>
          
        </div>
      </section>

      <section id='header-3'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-3'>Side Effects of Antipsychotics</a>
          </h2>
        </header>
        <div class='body'>
          <p>Side effects of antipsychotic medications are among the most common complaints in general psychiatry clinics and a major cause of non-compliance with medications.</p>
          
          <p>They are broadly divided into:</p>
          
          <ul>
            <li>The extrapyramidal side effects</li>
            <li>The anticholinergic side effects</li>
            <li>The antiadrenergic side effects</li>
            <li>Other effects</li>
          </ul>
          
          <section id='heading-3-1'>
            <header>
              <h3>
                <a aria-hidden href='#heading-3-1'>Extrapyramidal Side Effects</a>
              </h3>
            </header>
            <div class='body'>


              <ul>
                <li>Acute Dystonia</li>
                <li>Akathesia</li>
                <li>Parkinsonian-like Side Effect</li>
                <li>Tardive Dyskinesia</li>
                <li>Tardive Dystonia</li>
              </ul>
              
              <p>These are side effects of antipsychotics, especially typical medications. They result from the blockade of dopaminergic receptors at the basal ganglia and manifest with abnormal body movements. Major extrapyramidal side effects include:</p>
              
              <h4>Acute Dystonia</h4>
              <p>A common side effect characterized by sustained painful muscle spasms, acute dystonia occurs within days of commencing an antipsychotic, with 50% of cases happening within 48 hours.</p>
              
              <p>It is more common with butyrophenones and phenothiazines, affecting 3-10% of those exposed to antipsychotics.</p>
              
              <p><strong>Symptoms include:</strong></p>
              <ul>
                <li>Grimacing</li>
                <li>Torticollis</li>
                <li>Opisthotonus</li>
                <li>Oculogyric crisis</li>
                <li>Trismus</li>
                <li>Tongue protrusion</li>
              </ul>
              
              <p>It is usually more generalized in the young and more localized in the elderly, occasionally being confused with posturing or histrionic behavior.</p>
              
              <h4><em>Management</em></h4>
    
              <ol>
                <li>Review the medications</li>
                <li>Discontinue suspected agent if possible</li>
                <li>Emergency treatment with parenteral anticholinergics (e.g., benztropine, biperidine, procyclidine) in severe cases</li>
                <li>Oral anticholinergics (e.g., benzhexol) for mild cases</li>
                <li>The anticholinergic should be continued but tapered off gradually over 2 to 3 weeks</li>
                <li>Consider Amantadine</li>
              </ol>
              
              <h4>Akathesia</h4>
              
              <p>Akathesia is an unpleasant, distressing feeling of inner restlessness manifested as pacing, inability to sit still, rocking, or constant crossing and uncrossing of legs. The term is derived from the Greek word meaning inability to sit still and was first described by Haskovec in 1901.</p>
              
              <p>It typically occurs in the first two weeks of treatment, and risk factors include:</p>
              <ul>
                <li>Use of high doses of antipsychotics</li>
                <li>High-potency antipsychotics</li>
                <li>Rapid or sudden withdrawal of antipsychotics</li>
                <li>Intramuscular antipsychotics</li>
                <li>Organic brain disease</li>
                <li>Previous history of akathisia</li>
                <li>Concomitant use of other medications such as lithium</li>
              </ul>
              
              <p>Akathesia may be mistaken for restlessness, anxiety, or agitation in a psychotic patient.</p>
              
              <h4><em>Management of Akathesia</em></h4>
    
              <ol>
                <li>Review the medications</li>
                <li>Reduce the dose of antipsychotics if the clinical state of the patient permits</li>
                <li>Consider a switch to a lower potency antipsychotic</li>
                <li>Consider Beta blockers (e.g., propranolol, pindolol, betaxolol)</li>
                <li>Consider Anticholinergics</li>
                <li>Consider Benzodiazepines</li>
              </ol>
              
              <h4>Parkinsonian-like Side Effect</h4>
              
              <p>This is a frequent side effect of antipsychotic medications, occurring in about 20% of patients being treated with antipsychotics. It is a major cause of non-compliance with medications and typically appears after a few months of commencing medications.</p>
              
              <p>It is said to be due to D2 blockade at the nigrostriatal pathway and presents with symptoms such as:</p>
              <ul>
                <li>Tremors</li>
                <li>Rigidity with reduced arm swing</li>
                <li>Bradykinesia</li>
                <li>Stooped posture</li>
                <li>Festinant gait in severe cases</li>
              </ul>
              
              <h4><em>Management of Parkinsonian-like Side Effects</em></h4>
              
              <ol>
                <li>Reduce the dose of antipsychotics if the clinical state permits</li>
                <li>Consider Oral Anticholinergics</li>
                <li>Switch to another antipsychotic (e.g., atypicals)</li>
                <li>Consider Amantadine</li>
              </ol>
              
              <h4>Tardive Dyskinesia</h4>
    
              <p>Tardive Dyskinesia is a late-onset side effect of antipsychotics, often associated with long-term use but may occur in patients with schizophrenia who are not on antipsychotics.</p>
              
              <p><strong>Symptoms of Tardive Dyskinesia:</strong></p>
              <ul>
                <li>Involuntary repetitive purposeless movements, manifesting as:</li>
                <ul>
                  <li>Perioral chewing and sucking movements</li>
                  <li>Torticollis or retrocolis</li>
                  <li>Shoulder shrugging</li>
                  <li>Pelvic thrusting</li>
                  <li>Trunk twisting</li>
                  <li>Repeated movements of the fingers and legs</li>
                  <li>Hand clenching</li>
                </ul>
                <li>Most patients initially don‚Äôt notice these movements, and they are pointed out by others.</li>
                <li>When patients become aware, they may consciously suppress these movements for short periods of time.</li>
              </ul>
              
              <p>It is a very worrisome side effect.</p>
              
              <h4><em>Pathophysiology of Tardive Dyskinesia</em></h4>
    
              <ul>
                <li>Super sensitivity of post-synaptic D2 receptors due to prolonged blockade.</li>
                <li>GABA hypo-function.</li>
              </ul>
              
              <h4><em>Risk Factors for Tardive Dyskinesia</em></h4>
              
              <ul>
                <li>Chronic use of antipsychotics</li>
                <li>Previous history of head injury</li>
                <li>Organic brain disease</li>
                <li>Women</li>
                <li>Mood disorder</li>
                <li>Elderly</li>
                <li>Previous history of drug-induced akathisia</li>
                <li>Concomitant use of drugs that can induce akathisia</li>
              </ul>
              
              <h4><em>Management of Tardive Dyskinesia</em></h4>
              
              <ol>
                <li>Review the medications</li>
                <li>Reduce the dose of antipsychotics</li>
                <li>Reduce the dose of anticholinergics</li>
                <li>Increasing the dose of antipsychotics may give temporary relief</li>
                <li>Benzodiazepines</li>
                <li>Adrenergic agents such as propranolol, clonidine</li>
                <li>Anticonvulsants (e.g., valproate, gabapentin)</li>
                <li>Antioxidants (e.g., vitamin E)</li>
                <li>Consider switching to an atypical antipsychotic</li>
              </ol>
              
    
              <h4>Tardive Dystonia</h4>
    
              <p>Tardive Dystonia is the long-term persistence of a dystonic movement disorder. It presents similarly to acute dystonic reactions but persists for an extended period, sometimes even after the antipsychotic has been withdrawn.</p>
              
              <p>Treatment with anticholinergics is often not satisfactory.</p>
              
              <h4><em>Treatment of Tardive Dystonia</em></h4>
              
              <ol>
                <li>Discontinue medications if the patient‚Äôs clinical state permits.</li>
                <li>Switch to an atypical medication, especially clozapine.</li>
                <li>Consider injection of botulinum into the affected muscle group.</li>
              </ol>
              

            </div>
          </section>

          <section id='heading-3-2'>
            <header>
              <h3>
                <a aria-hidden href='#heading-3-2'>Antiadrenergic Side Effects</a>
              </h3>
            </header>
            <div class='body'>

              <ul>
                <li>Sedation</li>
                <li>Postural hypotension</li>
                <li>Inhibition of ejaculation</li>
                <li>Nasal congestion</li>
              </ul>

            </div>
          </section>

          <section id='heading-3-3'>
            <header>
              <h3>
                <a aria-hidden href='#heading-3-3'>Anticholinergic Side Effects</a>
              </h3>
            </header>
            <div class='body'>

          
               <ul>
                 <li>Dry mouth</li>
                 <li>Urinary hesitancy and retention</li>
                 <li>Blurred vision</li>
                 <li>Reduced sweating</li>
                 <li>Precipitation of glaucoma</li>
               </ul>
            </div>
          </section>


          <section id='heading-3-4'>
            <header>
              <h3>
                <a aria-hidden href='#heading-3-4'>Neuroleptic Malignant Syndrome (NMS)</a>
              </h3>
            </header>
            <div class='body'>
              
              <p>Neuroleptic Malignant Syndrome is a rare and fatal side effect of antipsychotics, occurring idiosyncratically, often within the first 10 days of initiating the use of antipsychotics. It occurs in 0.07% to 0.2% of patients on antipsychotics and is more common in females than males.</p>
              
              <p><strong>Risk factors for Neuroleptic Malignant Syndrome:</strong></p>
              <ul>
                <li>Rapid antipsychotic initiation</li>
                <li>Depot preparations</li>
                <li>High potency antipsychotics</li>
                <li>Previous history of NMS</li>
                <li>Affective disorder</li>
                <li>Organic brain disease</li>
                <li>Concomitant use of predisposing drugs</li>
              </ul>
              
              <h4><em>Symptoms of Neuroleptic Malignant Syndrome</em></h4>
    
              <p><strong>Motor:</strong></p>
              <ul>
                <li>Generalized muscular hypertonicity</li>
                <li>Stiffness of muscles of the throat and chest causing dysphagia and dyspnea</li>
                <li>Tremors</li>
                <li>Seizures</li>
              </ul>
              
              <p><strong>Mental:</strong></p>
              <ul>
                <li>Akinetic mutism, stupor, impaired consciousness, confusion, agitation</li>
              </ul>
              
              <p><strong>Autonomic:</strong></p>
              <ul>
                <li>Hyperpyrexia</li>
                <li>Increased sweating</li>
                <li>Increased salivation</li>
                <li>Hypo or hypertension</li>
                <li>Incontinence or retention of urine</li>
              </ul>
              
              <h4><em>Pathophysiology of Neuroleptic Malignant Syndrome</em></h4>
              
              <ul>
                <li>Blockade of D2 receptors at the striatum and the hypothalamus</li>
                <li>Sympathetic nervous system dysfunction</li>
              </ul>
              
              <h4><em>Complications of Neuroleptic Malignant Syndrome</em></h4>
              
              <ul>
                <li>Aspiration pneumonitis</li>
                <li>Renal failure</li>
                <li>Arrhythmias</li>
                <li>DIC (Disseminated Intravascular Coagulation)</li>
                <li>Respiratory failure</li>
              </ul>
              
              <h4><em>Management of Neuroleptic Malignant Syndrome</em></h4>
    
              <p><strong>It is a psychiatric emergency. Steps to take:</strong></p>
              <ol>
                <li>Resuscitate the patient.</li>
                <li>Stop the offending antipsychotic.</li>
                <li>Administer intravenous fluids.</li>
                <li>Alkalinization of urine.</li>
                <li>Treat muscle stiffness with benzodiazepines.</li>
                <li>Manage malignant hyperthermia with dantrolene, antipyretics, bromocriptine.</li>
                <li>Treat intercurrent infections.</li>
              </ol>
              
              <p>If the clinical state of the patient necessitates reintroduction of an antipsychotic, restart treatment cautiously with an atypical antipsychotic in low doses after about 2 weeks.</p>
              


            </div>
          </section>

          <section id='heading-3-5'>
            <header>
              <h3>
                <a aria-hidden href='#heading-3-5'>Other Side Effects</a>
              </h3>
            </header>
            <div class='body'>
              
              <p><strong>Cardiac Conduction Defects:</strong> Prolongation of QT interval (e.g., in pimozide, thioridazine)</p>
              <p><strong>Endocrine Side Effects:</strong> Amenorrhea, galactorrhea, breast tenderness, weight gain, impaired glucose tolerance, diabetes mellitus</p>
              <p><strong>Photosensitive Rashes:</strong> Chlorpromazine</p>
              <p><strong>Seizures</strong></p>
              <p><strong>Depression</strong></p>
              <p><strong>Eye Problems:</strong> Retinitis pigmentosa</p>
              <p><strong>Blood Dyscrasias:</strong> Commonly with clozapine</p>

            </div>
          </section>
  


          <section id='heading-3-6'>
            <header>
              <h3>
                <a aria-hidden href='#heading-3-6'>General Measures for Preventing Side Effects</a>
              </h3>
            </header>
            <div class='body'>
              <ol>
                <li>Give antipsychotics only to those who really need them.</li>
                <li>Enquire about previous side effects of antipsychotics.</li>
                <li>Start with a low dose and titrate upwards.</li>
                <li>Avoid the use of very high doses of antipsychotics, especially the typicals.</li>
                <li>Consider atypical antipsychotics first in patients who are antipsychotic na√Øve.</li>
                <li>Exercise cautious prescribing in the elderly and the very young.</li>
                <li>Avoid poly-pharmacy as much as possible.</li>
              </ol>

            </div>
          </section>



          

          
        </div>
      </section>

      <section id='header-4'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-4'>Depot Antipsychotics</a>
          </h2>
        </header>
        <div class='body'>

                   
          <p>Used when concerns around compliance. Examples include:</p>
          <ul>
            <li>Conventional: Zuclopenthixol (useful for agitated, aggressive, disturbed behavior), Flupenthixol (may have mood elevating effects), Fluphenazine (common for Extrapyramidal Side Effects)</li>
            <li>Atypical: Risperdal Consta ‚Äì onset of action 3 weeks, need oral Risperidone to supplement until peak plasma reached</li>
          </ul>
        </div>
      </section>

      <section id='header-5'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-5'>Antidepressants</a>
          </h2>
        </header>
        <div class='body'>
          <h4>Introduction</h4>

          <p>Depression is a heterogeneous disorder characterized and classified in various ways. According to the American Psychiatric Association's fourth edition (1994) of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), several diagnoses of affective disorders are possible.</p>
          
          <p>Major depression and dysthymia (minor) are pure depressive syndromes, whereas bipolar disorder and cyclothymic disorder signify depression in association with mania.</p>
          
          <h4>Amine Hypothesis</h4>
          
          <p>The amine hypothesis of mood postulates that brain amines, particularly norepinephrine (NE) and serotonin (5-HT), are neurotransmitters in pathways that function in the expression of mood.</p>
          
          <p>According to the hypothesis, a functional decrease in the activity of such amines is thought to result in depression, while a functional increase in activity results in mood elevation.</p>
          

          <h4>Classification</h4>

          <p><strong>Selective Serotonin Reuptake Inhibitors (SSRI)</strong></p>
          <ul>
            <li>Fluoxetine (Prozac)</li>
            <li>Sertraline (Zoloft)</li>
            <li>Paroxetine (Paxil)</li>
            <li>Fluvoxamine (Luvox)</li>
            <li>Citalopram (Celexa)</li>
            <li>Escitalopram (Lexapro)</li>
          </ul>
          
          <p><strong>Serotonin-Norepinephrine Reuptake Inhibitors (SNRI)</strong></p>
          <ul>
            <li>Venlafaxine (Effexor)</li>
            <li>Duloxetine (Cymbalta)</li>
          </ul>
          
          <p><strong>Serotonin Receptor Agonists and Antagonists/Reuptake Inhibitor (SARI)</strong></p>
          <ul>
            <li>Trazodone (Desyrel)</li>
            <li>Nefazodone</li>
          </ul>
          
          <p><strong>Norepinephrine-Dopamine Reuptake Inhibitors (NDRI)</strong></p>
          <ul>
            <li>Bupropion (Wellbutrin)</li>
          </ul>


          <p><strong>Tricyclic Antidepressants</strong></p>
          <ul>
            <li>Nortriptyline (Pamelor)</li>
            <li>Imipramine (Tofranil)</li>
            <li>Desipramine (Norpramin)</li>
            <li>Clomipramine (Anafranil)</li>
          </ul>
          
          <p><strong>Monoamine Uptake Inhibitors</strong></p>
          <ul>
            <li>Selegiline (EMSAM patch)</li>
            <li>Tranylcypromine (Parnate)</li>
            <li>Phenelzine (Nardil)</li>
            <li>Isocarboxazid (Marplan)</li>
          </ul>
          

          <h4>Absorption and Metabolism</h4>

          <p>Most antidepressants are fairly well absorbed after oral administration.</p>
          
          <p>Serum concentrations of most tricyclic antidepressants peak within several hours.</p>
          
          <p>Tricyclic antidepressants are oxidized by hepatic microsomal enzymes, followed by conjugation with glucuronic acid.</p>
          
          <p>They are lipophilic.</p>
          
          <p>Antidepressants are metabolized more rapidly by children and more slowly by patients over 60 years of age as compared with young adults.</p>
          
          <h4>Mechanism of Action</h4>

          <p>All known antidepressants affect monoamine neurotransmission, and this is believed to be their mechanism of action.</p>
          
          <p><strong>Tricyclic Antidepressants (TCA)</strong></p>
          <p><strong>SSRI (Selective Serotonin Reuptake Inhibitors)</strong></p>
          <p><strong>MAOI (Monoamine Oxidase Inhibitors)</strong></p>
          

          <h4>Pharmacologic Effects</h4>

          <ul>
            <li>Amine uptake blockade</li>
            <li>Sedation: mainserin, trimipramine, and dothiepin</li>
            <li>Muscarinic receptor blockade: more in amitriptyline and doxepin</li>
            <li>Cardiovascular effect: hypotension from Œ±-adrenoceptor blockade, depresses conduction</li>
            <li>Seizures: TCA and MAOI lower seizure threshold; maprotiline also</li>
          </ul>
          
          <h4>Indications</h4>
          
          <ul>
            <li>Major Depressive Disorder</li>
            <li>Bipolar Depression (acute treatment)</li>
            <li>Panic Disorder</li>
            <li>Social Phobia</li>
            <li>Generalized Anxiety Disorder</li>
            <li>Post-Traumatic Stress Disorder</li>
            <li>Obsessive-Compulsive Disorder (e.g., clomipramine and selective serotonin-reuptake inhibitors)</li>

            <li>Depression with Psychotic Features in Combination with Antipsychotic Drugs</li>
            <li>Bulimia Nervosa</li>
            <li>Neuropathic Pain (Tricyclic Drugs and Noradrenergic Reuptake Inhibitors)</li>
            <li>Insomnia (e.g., Trazodone, Amitriptyline)</li>
            <li>Enuresis (Imipramine Best Studied)</li>
            <li>Atypical Depression (Selective Serotonin-Reuptake Inhibitors or Monoamine Oxidase Inhibitors)</li>
            <li>Attention-Deficit Disorder with Hyperactivity (e.g., Desipramine, Bupropion)</li>
            <li>Others include Narcolepsy, Organic Mood Disorders</li>
          </ul>
          

          <h4>Withdrawal and Dependence</h4>

          <p>Occasionally, patients show physical dependence on the tricyclic antidepressants, with malaise, chills, muscle aches, and sleep disturbance following abrupt discontinuation, particularly of high doses.</p>
          
          <p>Similar reactions, along with gastrointestinal and sensory symptoms (paresthesias) and irritability, also occur with abrupt discontinuation of serotonin reuptake inhibitors, particularly with paroxetine and venlafaxine.</p>
          
          <p>Withdrawal reactions from MAO inhibitors may be severe, commencing 24 to 72 hours after drug discontinuation.</p>
          
          <h4>Choice of Antidepressants</h4>
          
          <p><strong>Cardiovascular Disease:</strong> SSRIs are the safest. Nortriptyline may also be used. Trazodone may cause a complete heart block.</p>
          
          <p><strong>Elderly:</strong> The half-lives and steady-state concentrations of the SSRIs are only minimally affected by age. Paroxetine may be an exception to this, and it may have an increased half-life in the elderly.</p>
          

          <h4>Choice of Antidepressants</h4>

          <p><strong>Medically Ill Patient:</strong> Nortriptyline and desipramine can be considered as alternatives for them.</p>
          
          <p><strong>Children and Adolescent:</strong> Nortriptyline and desipramine can be used as first-line agents since they have the least sedative, anticholinergic, and orthostatic hypotensive effects.</p>
          
          <p><strong>Nursing Mothers:</strong> Antidepressants are secreted in breast milk. Nursing should be deferred if antidepressant treatment is required.</p>
          
          <h4>Therapeutic Monitoring</h4>
          
          <p>To monitor side effects and drug reactions, consider the following:</p>
          
          <ul>
            <li>ECG and thorough cardiovascular examination</li>
            <li>Liver function test</li>
          </ul>
          
          <p>It is also important to note that while antidepressants may reduce the overall suicide rate, they may also transiently increase suicidal tendencies during periods of cessation or initiation of treatment.</p>
          

          <h4>Side Effects</h4>

          <p><strong>SSRIs</strong></p>
          
          <p>As a group, their main side effects are nausea, headache, neuromuscular restlessness (resembling akathisia), insomnia or sedation, and delayed ejaculation/anorgasmia.</p>
          
          <p>SSRIs combined with MAOIs are dangerous: a fatal serotonin syndrome may result.</p>
          
          <p>Nefazodone has caused life-threatening hepatotoxicity requiring liver transplantation. Duloxetine is also reported to cause liver dysfunction.</p>
          
          <h4>Serotonin Syndrome</h4>
          
          <p>First described for an interaction between fluoxetine and an MAOI.</p>
          
          <p>This life-threatening syndrome includes severe muscle rigidity, myoclonus, hyperthermia, cardiovascular instability, and marked CNS stimulatory effects, including seizures.</p>
          
          <p>Drugs implicated include MAOIs, TCAs, dextromethorphan, meperidine, and St. John's Wort.</p>
          
          <p>Treated with antiseizure drugs, muscle relaxants, and blockers of 5-HT receptors (e.g., cyproheptadine) have been used in the management of the syndrome.</p>
          

          <p><strong>Tricyclic Antidepressants (TCA)</strong></p>
          
          <ul>
            <li>Excessive sedation, lassitude, fatigue, and, occasionally, confusion;</li>
            <li>Sympathomimetic effects, including tachycardia, agitation, sweating, and insomnia;</li>
            <li>Atropine-like effects;</li>
            <li>Orthostatic hypotension, electrocardiogram (ECG) abnormalities, and cardiomyopathies;</li>
            <li>Tremor, paresthesias, and weight gain.</li>
          </ul>
          
          <p>Overdosage with tricyclics is extremely hazardous, and the ingestion of as little as a 2-week supply has been lethal. The "3 Cs"‚Äîcoma, convulsions, and cardiotoxicity‚Äîare characteristic.</p>
          
          <p><strong>MAO Inhibitors</strong></p>
          
          <p>Hypertensive crisis (consumption with tyramine).</p>
          
          <p>Foods that must be avoided include cured meats or fish, beer, red wine, all cheese except cottage and cream cheeses, and overripe fruits.</p>
          
          <p>Many over-the-counter cold and pain remedies must also be avoided.</p>
          

          <h4>Drug Interactions</h4>

          <p><strong>Tricyclic Drug Interactions</strong></p>
          
          <p>Include additive depression of the CNS with other central depressants, including ethanol, barbiturates, benzodiazepines, and opioids.</p>
          
          <p>TCA inhibit the effect of guanethidine, methylnorepinephrine, and clonidine by blocking its transport into sympathetic nerve endings.</p>
          
          <p><strong>SSRIs and virtually any agent with serotonin-potentiating activity can interact dangerously or even fatally with MAO inhibitors.</strong></p>
          
        </div>
      </section>

      <section id='header-6'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-6'> Lithium and Other Mood Stabilizing Agents</a>
          </h2>
        </header>
        <div class='body'>

          <p><strong>Lithium, Carbamazepine, and Sodium Valproate</strong></p>
          
          <h4>LITHIUM</h4>          
          <p><strong>Indications</strong></p>
          
          <ul>
            <li>Acute treatment of mania.</li>
            <li>Prophylaxis of unipolar and bipolar mood disorder.</li>
            <li>Augmentation therapy in resistant depression.</li>
            <li>Prevention of aggressive behavior in patients with learning difficulties.</li>
          </ul>
          
          <p><strong>Dosage and Plasma Concentration</strong></p>
          
          <p>Therapeutic and toxic doses are close.</p>
          
          <p>Essential to monitor plasma concentrations of Lithium during treatment.</p>
          
          <p>Measurement at 4 -7 days of treatment, then weekly for 3 weeks and then 6-weekly provided a satisfactory steady state has been achieved.</p>
          
          <p>If Lithium levels are stable, plasma monitoring at 2-3 months interval.</p>
          
          <p>Concentrations are usually measured 12 hrs after the last dose, usually the dose given at night.</p>
          
          <p>Lithium serum range:</p>
          <ul>
            <li>Previous: 0.7 ‚Äì 1.2mmol/l measured 12hrs after the last dose.</li>
            <li>Current: 0.5 ‚Äì 0.8 mmol/l.</li>
          </ul>
          
          <p>Note that many patients can be managed satisfactorily in clinical practice if their lithium levels are kept at 0.4-0.7mmol/l.</p>
          
          <p>In acute mania, 0.8 - 1.0mmol/l.</p>
          
          <p>Serious toxicity appears at concentrations > 2.0mmol/l,</p>
          <p>Early symptoms may appear above 1.2mmol/l.</p>
          
          <h4>Management of Patient with Lithium</h4>

          <p>Physical exam, BP, weight, E & U, Creatinine/Creatinine clearance, FBC, TFT ‚Äì T3, T4, TSH.</p>
          
          <p>Patient should not be on drugs that might interact with Lithium e.g. Diuretics (Frusemide safest), NSAID, ACE inhibitors, Angiotensin ‚Äì II receptor antagonists, antibiotics (spectinomycin/metronidazole).</p>
          
          <p>Lithium in combination with SSRIs and 5-HT1 agonists cause serotonin syndrome (pharmacodynamic interaction).</p>
          
          <p>Metoclopramide, domperidone, can enhance EPSE.</p>
          
          <p>Carbamazepine, phenytoin, calcium channel blockers, methyldopa can enhance neurotoxicity.</p>
          
          <p>Written guidelines should be provided for the patient and relative emphasizing the risk/benefit of Lithium.</p>
          
          <h4>Side Effects of Lithium:</h4>

          <ul>
            <li>Mild diuresis, tremor (fine), dry mouth, metallic taste.</li>
            <li>Muscle weakness, fatigue, thirst, polyuria, diabetes insipidus-like syndrome with pronounced polyuria and polydipsia.</li>
            <li>Weight gain, hair loss, coarsening of hair texture, thyroid gland enlargement/hypothyroidism.</li>
            <li>Reversible ECG changes, memory lapse.</li>
            <li>On long term, irreversible decline in renal tubular function.</li>
          </ul>
          
          <p><strong>Toxic Effects, Related to Dose:</strong></p>
          
          <ul>
            <li>Ataxia, poor coordination of limb movements, muscular twitching.</li>
            <li>Coarse tremor, slurred speech, confusion, coma, fits, and death.</li>
          </ul>
          
          <p>In case of toxicity, stop lithium.</p>
          
          <p>Encourage high fluid intake with extra sodium chloride to stimulate osmotic diuresis.</p>
          
          <p>Renal dialysis may be indicated.</p>
          
          <p><strong>Note:</strong> Dehydration can cause lithium levels to rise, as in gastroenteritis and infections.</p>
          
          <h4>Lithium and Pregnancy</h4>

          <p>Absolutely contraindicated in the first trimester (high risk of fetal abnormality Ebstein anomaly).</p>
          
          <p>The decision to continue with Lithium should be cautiously considered.</p>
          
          <p><strong>Contraindications:</strong></p>
          
          <ul>
            <li>Renal failure, cardiac failure, recent myocardial infarction, chronic diarrhea, inability to observe necessary precautions.</li>
          </ul>
          
          <p><strong>Stopping Lithium:</strong></p>
          
          <p>Discontinue Lithium slowly over a period of several weeks.</p>
          
          <p>Review yearly need to continue Lithium.</p>
          
          <p>Compelling reasons must be established to take Lithium for more than 5 years.</p>
          
        <h4>CARBAMAZEPINE</h4>          
          <ul>
            <li>Patients refractory to Lithium</li>
            <li>Management of acute mania</li>
            <li>Prophylaxis of bipolar disorder</li>
            <li>Drug-resistant depression</li>
            <li>Frequent mood swings and mixed affective states for which carbamazepine may be more effective than Lithium.</li>
            <li>Added to Lithium in patients who have shown a partial response to Lithium; risk of neurotoxicity.</li>
            <li>Monitor WBC in the first 3 months of treatment - risk of lowered WBC count.</li>
            <li>Stevens-Johnson Syndrome.</li>
          </ul>
          

          <h4>SODIUM VALPROATE</h4>

          <ul>
            <li>Acute and continuation treatment of mania.</li>
            <li>Management of patients with mixed affective state.</li>
            <li>Prophylaxis in mania/depression.</li>
            <li>Acute mania and maintenance treatment of bipolar disorder.</li>
            <li>Bipolar depression (questionable).</li>
            <li>Combination with Lithium in bipolar patients who have shown partial remission to Lithium.</li>
            <li>In combination with carbamazepine.</li>
            <li>In combination with antipsychotic or antidepressants for patients who continue to show episodes of mood disturbance.</li>
          </ul>
          
          <p><strong>Advantages:</strong></p>
          
          <ul>
            <li>Better tolerability than lithium.</li>
            <li>Can be loaded rapidly.</li>
            <li>Once-a-day formulation available.</li>
          </ul>
          
          <p><strong>Disadvantages:</strong></p>
          
          <ul>
            <li>Drug-drug interactions.</li>
            <li>Fetal abnormalities.</li>
          </ul>
          

          <h4>LAMOTRIGINE and GABAPENTIN</h4>

          <p>Use in bipolar patients when standard agents are poorly tolerated or unsuccessful. See British National Formulary.</p>
          
          <h4>Other Anticonvulsants</h4>
          
          <ul>
            <li>Gabapentin</li>
            <li>Pregabalin</li>
            <li>Levetiracetam</li>
            <li>Tiagabine</li>
            <li>Topiramate</li>
          </ul>
          
          <h4>PSYCHOSTIMULANTS</h4>
          
          <ul>
            <li>Caffeine, methylphenidate, amphetamine; cocaine is also a powerful stimulant; but with high dependence.</li>
            <li>Amphetamine less prescribed because of dependence, used in adults for narcolepsy, no longer used for depression.</li>
            <li>Methylphenidate ‚Äì attention deficit disorder.</li>
            <li>Psychostimulants for ?? Elderly depressed with concomitant medical illness.</li>
          </ul>
          
        </div>
      </section>







      <hr style="margin: 3rem 0;">

      <!-- PRACTICE QUESTIONS CONTAINER -->

      <div class="custom-card" id="custom-card-2">
        <div class="icon"><img src="../images/icons/practice-questions.png" alt="Icon" class="icon"></div>
        <div class="title"> 
          <h2>Practice Questions</h2>
        </div>
        <div class="line">
          <p>Check how well you grasp the concepts by answering the following questions...</p>
        </div>
        <div class="content">
          <ol>
            <li><i>This content is not available yet.</i></li>
          </ol>
        </div>
        <div class="read-more" onclick="toggleContent('custom-card-2')">Read More üç™</div>
      </div>

      <!-- END OF PRACTICE QUESTIONS CONTAINER -->


      <!-- CONTACT- COMMENT AND CONTRIBUTORS CONTAINER -->
      <div class="contact">
        <div class="comment-container">
          <div class="comment-icon">
            <!-- Add your icon image here -->
            <img src="../images/icons/comment.png" alt="Comment Icon">
          </div>
          <div class="comment-text">
            <!-- Add your text here -->
            <p>Send your comments, corrections, explanations/clarifications and requests/suggestions </p>
          </div>
          <a href="https://chat.whatsapp.com/FtDdb6uEFYzBCnTnMgm2Z1" class="comment-button">
            here
            <img src="../images/icons/whatsapp.png" alt="Image Icon">
          </a>
        </div>

        <div class="contributors-container">

          <h2 class="contributors-header">Contributors</h2>
  
        <br>
            <div class="contributor-box">
                <img class="contributor-avatar" src="../images/icons/woman.png" alt="Contributor 1 Avatar">
                <div class="contributor-info">
                    <h3 class="contributor-name">Jane Smith</h3>
                    <p class="contributor-description">She is not a real contributor.</p>
                    <div class="social-links">
                        <a href="#" target="_blank" class="social-icon">
                            <img src="../images/icons/whatsapp.png" alt="Social Icon 1">
                        </a>
                        <a href="#" target="_blank" class="social-icon">
                            <img src="../images/icons/twitter.png" alt="Social Icon 2">
                        </a>
                    </div>
                </div>
            </div>
        
            <div class="contributor-box">
                <img class="contributor-avatar" src="../images/icons/man.png" alt="Contributor 2 Avatar">
                <div class="contributor-info">
                    <h3 class="contributor-name">John Doe</h3>
                    <p class="contributor-description">He is not a real contributor.</p>
                    <div class="social-links">
                      <a href="#" target="_blank" class="social-icon">
                        <img src="../images/icons/whatsapp.png" alt="Social Icon 1">
                    </a>
                    <a href="#" target="_blank" class="social-icon">
                        <img src="../images/icons/linkedin.png" alt="Social Icon 2">
                    </a>
                    </div>
                </div>
            </div>
        
        </div>
      </div>

            <!-- END OF CONTACT- COMMENT AND CONTRIBUTORS CONTAINER -->
    </article>
   </article>
   <div style="height: 300px;"></div>
  </main>

  <footer>
    <div class="footer-container">
        <div>
          <p id="popup-trigger">disclaimer</p>

          <!-- The pop-up dive content -->
          <div id="popup" class="popup">
            <p>The contents on this ‚Äòwebsite‚Äô are for educational purposes only. The creators and operators of this website make no warranties, express or implied, regarding the accuracy, currency, or completeness of the information provided on the website. They shall not be held responsible for any errors or omissions, or for any actions taken based on the information provided on this website.</p>
            <button class="popup-close" onclick="closePopup()">Close</button>
          </div>    
          <p><a href="../about-temp2.html">about</a> </p>   
          <p><a href="../contribute.html">contribute</a> </p>
          <p><a href="https://chat.whatsapp.com/FtDdb6uEFYzBCnTnMgm2Z1">say hiüëã</a> </p>
        </div>

        <div class="footer-beta">
          <p>thisisatestversion</p>
        </div>
    </div>
  </footer>
<!------------  SCROLL UP ----------->
<a href="#" class="scrollup" id="scroll-up"> 
  <i class="ri-arrow-up-fill scrollup__icon"></i>
</a>
<script src="../main.js"></script>
<script src="../modal.js"></script>
<script src="../notes-sidebar.js"></script>
</body>
</html>
 
